ALTMAN MICHAEL SETH

Director at Perceptive Capital Solutions Corp · on record since Jun 13, 2024
Chief Business Officer at Perceptive Capital Solutions Corp · on record since Jun 13, 2024
10% owner at Perceptive Capital Solutions Corp · on record since Jun 13, 2024
10% owner at Adagio Medical Holdings, Inc. · on record since Aug 1, 2024
Director at Nautilus Biotechnology, Inc. · on record since Jun 11, 2021
Director at ARYA SCIENCES ACQUISITION CORP. · on record since Oct 5, 2018
Chief Financial Officer at ARYA SCIENCES ACQUISITION CORP. · on record since Oct 5, 2018
Director at Lyra Therapeutics, Inc. · on record since Apr 30, 2020
Director at ARYA Sciences Acquisition Corp II · on record since Jun 9, 2020
Chief Financial Officer at ARYA Sciences Acquisition Corp II · on record since Jun 9, 2020
10% owner at ARYA SCIENCES ACQUISITION CORP. · on record since Aug 11, 2020
Director at ARYA Sciences Acquisition Corp IV · on record since Feb 25, 2021
Chief Financial Officer at ARYA Sciences Acquisition Corp IV · on record since Feb 25, 2021
10% owner at ARYA Sciences Acquisition Corp IV · on record since Feb 25, 2021
Director at ARYA Sciences Acquisition Corp V · on record since Jul 15, 2021
Chief Financial Officer at ARYA Sciences Acquisition Corp V · on record since Jul 15, 2021
10% owner at ARYA Sciences Acquisition Corp V · on record since Jul 15, 2021

Insider trading activity of ALTMAN MICHAEL SETH

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Price	Value · USD	Src
ARYA Sciences Acquisition Corp IV	Jul 31, 2024	OtherD	-2,647,500	—	—	SEC
ARYA Sciences Acquisition Corp IV	Jul 31, 2024	Other	-499,000	—	—	SEC
ARYA Sciences Acquisition Corp IV	Jul 31, 2024	OtherD	-1,000,000	—	—	SEC
Nautilus Biotechnology, Inc.	Jun 17, 2024	AwardD	45,000	0.00 USD	$0	SEC
Lyra Therapeutics, Inc.	Jun 14, 2024	AwardD	30,000	0.00 USD	$0	SEC
Perceptive Capital Solutions Corp	Jun 13, 2024	Award	286,250	10.00 USD	$2.9M	SEC
Lyra Therapeutics, Inc.	Jul 5, 2023	AwardD	20,000	0.00 USD	$0	SEC
Nautilus Biotechnology, Inc.	Jun 20, 2023	AwardD	45,000	0.00 USD	$0	SEC
Lyra Therapeutics, Inc.	Jun 21, 2022	AwardD	7,250	0.00 USD	$0	SEC
Nautilus Biotechnology, Inc.	Jun 17, 2022	AwardD	86,467	0.00 USD	$0	SEC
ARYA Sciences Acquisition Corp V	Jul 15, 2021	Award	499,000	10.00 USD	$5M	SEC
Nautilus Biotechnology, Inc.	Jun 11, 2021	AwardD	44,435	0.00 USD	$0	SEC
Nautilus Biotechnology, Inc.	Jun 11, 2021	Other	-499,000	—	—	SEC
Nautilus Biotechnology, Inc.	Jun 11, 2021	OtherD	-3,647,500	—	—	SEC
Nautilus Biotechnology, Inc.	Jun 11, 2021	Other	499,000	—	—	SEC
Nautilus Biotechnology, Inc.	Jun 11, 2021	Other	3,647,500	—	—	SEC
Lyra Therapeutics, Inc.	May 28, 2021	AwardD	7,250	0.00 USD	$0	SEC
ARYA Sciences Acquisition Corp IV	Mar 2, 2021	Award	499,000	10.00 USD	$5M	SEC
ARYA SCIENCES ACQUISITION CORP.	Aug 11, 2020	Other	499,000	10.00 USD	$5M	SEC
ARYA Sciences Acquisition Corp II	Jun 9, 2020	Other	499,000	10.00 USD	$5M	SEC
Lyra Therapeutics, Inc.	May 1, 2020	AwardD	14,500	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ARYA Sciences Acquisition Corp IV	Jul 31, 2024	OtherD	-2,647,500	—	—	SEC
ARYA Sciences Acquisition Corp IV	Jul 31, 2024	Other	-499,000	—	—	SEC
ARYA Sciences Acquisition Corp IV	Jul 31, 2024	OtherD	-1,000,000	—	—	SEC
Nautilus Biotechnology, Inc.	Jun 17, 2024	AwardD	45,000	0.00 USD	$0	SEC
Lyra Therapeutics, Inc.	Jun 14, 2024	AwardD	30,000	0.00 USD	$0	SEC
Perceptive Capital Solutions Corp	Jun 13, 2024	Award	286,250	10.00 USD	$2.9M	SEC
Lyra Therapeutics, Inc.	Jul 5, 2023	AwardD	20,000	0.00 USD	$0	SEC
Nautilus Biotechnology, Inc.	Jun 20, 2023	AwardD	45,000	0.00 USD	$0	SEC
Lyra Therapeutics, Inc.	Jun 21, 2022	AwardD	7,250	0.00 USD	$0	SEC
Nautilus Biotechnology, Inc.	Jun 17, 2022	AwardD	86,467	0.00 USD	$0	SEC
ARYA Sciences Acquisition Corp V	Jul 15, 2021	Award	499,000	10.00 USD	$5M	SEC
Nautilus Biotechnology, Inc.	Jun 11, 2021	AwardD	44,435	0.00 USD	$0	SEC
Nautilus Biotechnology, Inc.	Jun 11, 2021	Other	-499,000	—	—	SEC
Nautilus Biotechnology, Inc.	Jun 11, 2021	OtherD	-3,647,500	—	—	SEC
Nautilus Biotechnology, Inc.	Jun 11, 2021	Other	499,000	—	—	SEC
Nautilus Biotechnology, Inc.	Jun 11, 2021	Other	3,647,500	—	—	SEC
Lyra Therapeutics, Inc.	May 28, 2021	AwardD	7,250	0.00 USD	$0	SEC
ARYA Sciences Acquisition Corp IV	Mar 2, 2021	Award	499,000	10.00 USD	$5M	SEC
ARYA SCIENCES ACQUISITION CORP.	Aug 11, 2020	Other	499,000	10.00 USD	$5M	SEC
ARYA Sciences Acquisition Corp II	Jun 9, 2020	Other	499,000	10.00 USD	$5M	SEC
Lyra Therapeutics, Inc.	May 1, 2020	AwardD	14,500	0.00 USD	$0	SEC